Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characterization of tyrosine sulphation in rFVIII (turoctocog alfa) expressed in CHO and HEK-293 cells.

× No keyword cloud information.

6 in total

1. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors: Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal: ACS Chem Biol Date: 2013-06-26 Impact factor: 5.100

Review 2. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors: Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal: Blood Date: 2016-09-01 Impact factor: 22.113

3. Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report.

Authors: Masahiro Takeyama; Keiji Nogami; Ryohei Kobayashi; Kenichi Ogiwara; Akira Taniguchi; Yasuaki Nakanishi; Yusuke Inagaki; Yasuhito Tanaka; Midori Shima
Journal: Int J Hematol Date: 2018-01-30 Impact factor: 2.490

Review 4. Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.

Authors: Massimo Morfini; Stefano Gherardini
Journal: Ther Adv Hematol Date: 2018-06-05

Review 5. A new recombinant factor VIII: from genetics to clinical use.

Authors: Elena Santagostino
Journal: Drug Des Devel Ther Date: 2014-12-12 Impact factor: 4.162

Review 6. Turoctocog alfa (NovoEight®)--from design to clinical proof of concept.

Authors: Mirella Ezban; Knud Vad; Marianne Kjalke
Journal: Eur J Haematol Date: 2014-05-28 Impact factor: 2.997

6 in total